Abpro Stock

HealthTech

Abpro is a biotechnology company focused on treating and curing diseases in patients. By leveraging synthetic biology and immunology, Abpro develops medications targeting novel and challenging diseases. The company aids biotechnology and pharmaceutical firms in creating numerous therapeutic antibodies against traditionally difficult targets. This support helps medical professionals develop antibody therapies that significantly enhance the lives of patients dealing with severe and life-threatening illnesses.